Greenberg Traurig’s Tel Aviv office is collaborating with partners BNY Mellon and H.C. Wainwright & Co. LLC to host a morning roundtable focused on capital markets options for the life sciences industry.

The event will take place February 27th, 9:00 at Greenberg Traurig’s Tel Aviv office located in the Azrieli Round Tower (30th Floor).

Topics to be discussed include:

  • Preparing for going public
  • Various ways to go public and determining the appropriate route: reverse merger, full IPO, ADR vs. ordinary shares, registered direct offering, PIPE transactions, at-the-market offering
  • Post IPO alternatives
  • Relevant legal and business issues for companies going public
  • Deciding upon and working with investment bankers

Leading the discussion:

Bob Grossman
Chair, Israel Practice;
Corporate, Securities and M&A Shareholder – Greenberg Traurig

Joshua Samek
Corporate, Securities and M&A Shareholder – Greenberg Traurig

Benjamin Brisedou
Vice President – BNY Mellon

Oded Spindel
Vice President  – H.C. Wainwright & Co. LLC

Please click here to register